Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2017
At a glance
- Drugs Lonafarnib (Primary) ; Ritonavir
- Indications Hepatitis D
- Focus Adverse reactions; Therapeutic Use
- Acronyms LOWR HDV - 3
- 21 Apr 2017 According to an Eiger BioPharmaceuticals, Inc. media release, data from the study has been presented at the The International Liver Congress 2017.
- 21 Apr 2017 Results from the LOWER HDV program published in an Eiger BioPharmaceuticals, Inc. media release.
- 06 Apr 2017 Status changed from active, no longer recruiting to completed, according to a Eiger BioPharmaceuticals, Inc. media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History